Haemonetics (HAE)
(Delayed Data from NYSE)
$94.40 USD
+1.07 (1.15%)
Updated May 3, 2024 03:59 PM ET
After-Market: $94.40 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/9/24 |
---|---|
Current Quarter | 0.88 |
EPS Last Quarter | 1.04 |
Last EPS Surprise | 7.22% |
ABR | 1.83 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 3.95 |
Next Year | 4.24 |
EPS (TTM) | 3.85 |
P/E (F1) | 22.01 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 326.95M | 328.63M | 1.29B | 1.35B |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 329.58M | 334.65M | 1.30B | 1.41B |
Low Estimate | 324.42M | 325.24M | 1.29B | 1.32B |
Year ago Sales | 304.42M | 311.33M | 1.17B | 1.29B |
Year over Year Growth Est. | 7.40% | 5.56% | 10.62% | 4.37% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.88 | 1.01 | 3.95 | 4.24 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | 0.88 | 0.96 | 3.94 | 4.17 |
High Estimate | 0.88 | 1.05 | 3.95 | 4.30 |
Low Estimate | 0.87 | 0.96 | 3.94 | 4.17 |
Year ago EPS | 0.77 | 1.05 | 3.03 | 3.95 |
Year over Year Growth Est. | 14.29% | -3.81% | 30.36% | 7.43% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 1 | 0 | 1 |
Up Last 30 Days | 0 | 1 | 0 | 1 |
Up Last 60 Days | 0 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 0 | 1 |
Down Last 60 Days | 0 | 1 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Current | 0.88 | 1.01 | 3.95 | 4.24 |
7 Days Ago | 0.88 | 1.01 | 3.95 | 4.24 |
30 Days Ago | 0.88 | 1.01 | 3.95 | 4.24 |
60 Days Ago | 0.88 | 1.01 | 3.95 | 4.23 |
90 Days Ago | 0.90 | 0.99 | 3.89 | 4.19 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.88 | 1.01 | 3.95 | 4.24 |
Zacks Consensus Estimate | 0.88 | 1.01 | 3.95 | 4.24 |
Earnings ESP | 0.00% | -0.50% | 0.00% | -0.12% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.04 | 0.99 | 1.05 | 0.77 | NA |
Estimate | 0.97 | 0.94 | 0.76 | 0.68 | NA |
Difference | 0.07 | 0.05 | 0.29 | 0.09 | 0.13 |
Surprise | 7.22% | 5.32% | 38.16% | 13.24% | 15.99% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more